Correction: Pharmacokinetics and nephrotoxicity of cisplatin modulated by combination therapy with brusatol

Nan Guo; Yahui Zhang; Guiyan Yuan; Xiaoran Zhang; Wen Zhang; Qing Wen

PMC · DOI:10.3389/fphar.2026.1809629·March 2, 2026

Correction: Pharmacokinetics and nephrotoxicity of cisplatin modulated by combination therapy with brusatol

Nan Guo, Yahui Zhang, Guiyan Yuan, Xiaoran Zhang, Wen Zhang, Qing Wen

PDF

Open Access

Abstract

Linked entities

Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.

Chemicals2

cisplatin brusatol

Figures1

Click any figure to enlarge with its caption.

Keywords

brusatolcisplatindrug interactionHPLC-MSnephrotoxicity

Peer Reviews

No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.

Videos

No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.

Taxonomy

TopicsChemotherapy-induced organ toxicity mitigation · Cancer Treatment and Pharmacology · Chemotherapy-induced cardiotoxicity and mitigation

Full text

There was a mistake in Figure 2 as published. The middle panel of the figure was missing the caption ‘Kidney’. The corrected Figure 2 appears below.

The original article has been updated.